M. Ali Nasseri | Medicine and Health Sciences | Innovative Research Award

Published on by Research Hypothesis

Innovative Research Award

M. Ali Nasseri · Technical University of Munich · Germany

Researcher profile
M. Ali Nasseri
Affiliation Technical University of Munich
Country Germany
Scopus ID 55849349900
Documents 78
Citations 1,160
h-index 19
Subject area Medicine and Health Sciences
Event International Research Hypothesis Excellence Award
ORCID 0000-0002-9764-5731

Innovative Research Award is the title of this academic recognition profile concerning M. Ali Nasseri, whose supplied researcher information associates him with the Technical University of Munich in Germany and the subject area of Medicine and Health Sciences. The profile presents the bibliometric indicators provided for the researcher and outlines considerations relevant to evaluating research contributions in the context of the International Research Hypothesis Excellence Award. The information should be checked against authoritative researcher records before being used for formal recognition or bibliometric comparisons.[1][2]

Abstract

This article presents an academic recognition profile for M. Ali Nasseri in the context of the Innovative Research Award and the International Research Hypothesis Excellence Award. The supplied profile data lists 78 documents, 1,160 citations, and an h-index of 19, with Medicine and Health Sciences identified as the relevant subject area. These bibliometric values provide a quantitative starting point for describing research output and citation activity. However, the figures alone do not establish the originality, methodological quality, clinical relevance, or practical impact of individual studies. A comprehensive assessment would also require examination of verified publications, research methods, scholarly contributions, and independent evaluation criteria.[1][3]

Keywords

Innovative Research Award; M. Ali Nasseri; Medicine and Health Sciences; research evaluation; bibliometrics; citation analysis; h-index; scholarly publications; research impact; International Research Hypothesis Excellence Award; academic recognition; scientific innovation.

Introduction

Research recognition programs provide a framework for identifying and acknowledging scholarly contributions across scientific disciplines. In medicine and health sciences, meaningful evaluation can involve the originality of research questions, the robustness of study design, the reproducibility of findings, ethical research practices, and the potential contribution of results to clinical or public health knowledge. Bibliometric measures can support this process, but they should be interpreted alongside qualitative evidence and the context in which the research was produced.[3][4]

This profile organizes the supplied information about M. Ali Nasseri into a structured academic overview. It is intended as a presentation of researcher information and award-related considerations, rather than an independently verified biography or an announcement that an award has been granted. Researcher identities, institutional affiliations, publication records, and award outcomes should be confirmed through their respective authoritative sources before publication.

Research Profile

The supplied information identifies M. Ali Nasseri with the Technical University of Munich in Germany and associates the profile with Medicine and Health Sciences. It reports 78 documents, 1,160 citations, and an h-index of 19. These values are presented as user-provided figures and have not been independently verified for this article. Researcher databases may display different values depending on author disambiguation, database coverage, document types, citation-update dates, and profile-merging practices.[1][2]

The supplied ORCID identifier is 0000-0002-9764-5731. ORCID provides persistent researcher identifiers that can help distinguish scholars with similar names and connect them to their research outputs. An ORCID record may contain information entered by the researcher or added through authorized integrations; its contents should therefore be reviewed directly when verifying a person’s biography, affiliations, and publications.[2]

Research Contributions

Assessing a researcher’s contributions requires examining the substance of their scholarly work, including the questions investigated, the methods applied, the reliability of the findings, and the relevance of the results to the wider research community. In medicine and health sciences, additional considerations may include clinical significance, patient safety, ethical oversight, transparent reporting, and the extent to which findings can be reproduced or translated into practice.[3][4]

The supplied profile does not include a verified publication list, individual study titles, abstracts, or a detailed research statement. Accordingly, specific discoveries, clinical advances, inventions, or methodological innovations cannot be attributed to M. Ali Nasseri on the basis of the available information alone. A reliable account of research contributions should be prepared after reviewing the researcher’s verified publications and relevant supporting evidence.

Publications

The supplied Scopus profile information reports 78 documents. This figure is included as provided and should not be treated as a confirmed current total until the linked author record has been checked. A document count may include different publication types, and a researcher’s database profile may contain records that require author-level verification to distinguish their own work from that of other researchers with similar names.[1]

A publication list suitable for an academic recognition profile should include verified bibliographic details, such as author names, article title, journal or conference title, year of publication, volume and issue where applicable, page range or article number, and DOI when available. Publications should be selected for relevance and evidentiary value rather than solely for citation frequency. No individual publication titles or DOI identifiers have been supplied for this profile, so specific articles cannot be listed reliably here.

For additional verification, the researcher’s Scopus record and ORCID profile may be consulted through the external links below. The Scopus identifier in the supplied infobox is 55849349900, while the provided profile URL contains a different author identifier, 55322962400, in its displayed link text. This discrepancy should be resolved before publication to ensure that the correct author record is linked. The URL used in this article follows the identifier 55849349900 supplied for the profile.

Research Impact

The supplied bibliometric figures are 1,160 citations and an h-index of 19 across 78 documents. The h-index is a citation-based indicator that combines publication output with citation frequency: a value of 19 generally means that at least 19 indexed publications have each received at least 19 citations within the database and at the time of measurement. The indicator does not directly measure methodological quality, originality, societal value, or the clinical importance of research.[5]

Citation counts can vary across scholarly databases because each service indexes different journals, proceedings, books, and other research outputs. They can also change over time as new publications are indexed and citation records are updated. For a fair assessment, the database, retrieval date, author identity, and calculation method should be documented. Quantitative indicators should be interpreted alongside expert assessment and evidence of the researcher’s actual contributions.[3][5]

Research impact may extend beyond citations to include changes in professional practice, contributions to clinical guidance, data and software resources, interdisciplinary collaboration, public health outcomes, and knowledge dissemination. These dimensions require appropriate evidence and should not be inferred from citation metrics alone.

Award Suitability

The International Research Hypothesis Excellence Award is the event identified for this profile. The supplied information provides a basis for organizing the researcher’s stated bibliometric indicators within an academic recognition page. However, these figures alone are not sufficient to determine eligibility, establish award suitability, or confirm that the researcher has received an award.

A balanced evaluation for an innovative research award could consider the originality and significance of the research hypothesis, the quality of supporting evidence, methodological rigor, reproducibility, ethical compliance, publication record, contribution to the relevant field, and potential for advancing scientific understanding. Where applicable, reviewers may also consider translational relevance, interdisciplinary value, and documented benefits to health or society. These are general assessment considerations, not a claim about the event’s official criteria.[3][4]

Before a final award-related statement is published, the organizers’ official eligibility rules and evaluation procedures should be consulted. The candidate’s identity, affiliation, publication record, and supporting documentation should be verified, and any selection outcome should be reported only when confirmed by the award organizers. This approach distinguishes an informational research profile from a formal award announcement.

Conclusion

This academic profile summarizes the information supplied for M. Ali Nasseri, including the stated affiliation with the Technical University of Munich, the subject area of Medicine and Health Sciences, and the reported bibliometric figures of 78 documents, 1,160 citations, and an h-index of 19. These details provide a structured starting point for researcher identification and academic recognition. They should be confirmed against authoritative records before being treated as current or independently established facts.

A defensible assessment of innovative research requires more than publication and citation totals. Verified scholarly outputs, transparent methodology, originality, reproducibility, ethical standards, and demonstrable contributions to the field are important components of a comprehensive review. The profile should therefore be updated with verified publications, relevant DOI records, and confirmed award information as those details become available.

References

  1. Elsevier. (n.d.). Scopus Author Search and author profiles. Scopus. Consult the author record to verify the researcher’s identifier, indexed documents, citations, and h-index.
    https://www.scopus.com/
  2. ORCID. (n.d.). ORCID: Connecting research and researchers. ORCID provides persistent identifiers that help distinguish researchers and connect them with scholarly outputs.
    https://orcid.org/
  3. Hicks, D., Wouters, P., Waltman, L., de Rijcke, S., & Rafols, I. (2015). Bibliometrics: The Leiden Manifesto for research metrics. Nature, 520, 429–431.
    DOI: https://doi.org/10.1038/520429a
  4. San Francisco Declaration on Research Assessment (DORA). (2012; subsequent updates available). Declaration on Research Assessment. DORA advocates evaluating research on its merits and avoiding overreliance on journal-based metrics.
    https://sfdora.org/read/
  5. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    DOI: https://doi.org/10.1073/pnas.0507655102

Daniel Alfaiate | Medicine | Research Hypothesis Excellence Award

Published on by Research Hypothesis

Research Hypothesis Excellence Award

Daniel Alfaiate
Instituto Politécnico de Castelo Branco, Portugal

Daniel Alfaiate
Affiliation Instituto Politécnico de Castelo Branco
Country Portugal
Scopus ID 58158006300
Documents 3
Citations 31
h-index 2
Subject Area Medicine
Event International Research Hypothesis Excellence Award
ORCID 0000-0002-5581-4242

Daniel Alfaiate the Research Hypothesis Excellence Award recognizes research activity characterized by a clearly defined scientific problem, systematic investigation, and contributions that can inform further study. Daniel Alfaiate is affiliated with the Instituto Politécnico de Castelo Branco in Portugal and has a publication record centered on sleep medicine, obstructive sleep apnea, sleep physiology, electroencephalography, and the effects of medication on sleep architecture. The documented publications provide a basis for assessing the researcher’s alignment with an international research recognition program in medicine.

Abstract

Daniel Alfaiate’s documented research profile is focused on clinical and physiological aspects of sleep and respiratory medicine. His publications examine topics including psychotropic medication and sleep architecture, obstructive sleep apnea and hematological parameters, wakefulness electroencephalography in patients with obstructive sleep apnea, and body posture among patients receiving non-invasive ventilation. These studies collectively address clinically relevant questions involving sleep physiology, respiratory disorders, diagnostic assessment, and treatment-related factors. The available record reports three documents, 31 citations, and an h-index of 2, providing bibliometric context for evaluating the researcher’s scholarly activity.[1] [2]

Keywords

Daniel Alfaiate; sleep medicine; obstructive sleep apnea; sleep architecture; polysomnography; electroencephalography; non-invasive ventilation; respiratory medicine; psychotropic medication; clinical research; medical research; research hypothesis; Portugal.

Introduction

Sleep medicine integrates clinical observation, physiological measurement, diagnostic technologies, and therapeutic evaluation to investigate disorders affecting sleep and breathing. Obstructive sleep apnea is characterized by recurrent episodes of upper-airway obstruction during sleep and can be studied through clinical assessment and objective sleep-related measurements. Research involving polysomnography, electroencephalography, respiratory parameters, and related physiological indicators can therefore contribute to a more detailed understanding of patient characteristics and treatment considerations.[1] [2] [3] [4]

Research Profile

Daniel Alfaiate is affiliated with the Instituto Politécnico de Castelo Branco in Portugal. The supplied bibliometric profile identifies Scopus Author ID 58158006300 and reports three documents, 31 citations, and an h-index of 2. These values represent the supplied research-profile information and should be interpreted in relation to the indexing date and database coverage.

Research Contributions

The research record contains several contributions to the study of sleep and respiratory disorders. A recent article in the European Journal of Pharmacology investigates the class-specific and cumulative effects of psychotropic medication on sleep architecture using polysomnographic retrospective data. This study addresses the relationship between medication exposure and objectively measured sleep characteristics, providing a clinical pharmacology perspective on sleep physiology. [1]

Publications

The supplied publication record includes the following works. DOI identifiers are provided where available and link directly to the corresponding DOI resolution service.

  1. Alfaiate, D.; Silva, P.; Guerra, P.; Pinto, N.; Pereira, A. “Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study.” European Journal of Pharmacology, 2026-08.
  2. Guerra, P.; Alfaiate, D.; Pinto, N.; Pereira, T.; Pereira, A. “Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study.” Sleep and Breathing, 2025.
  3. Pereira, I.; Guerra, P.; Pinto, N.; Alfaiate, D.; Pereira, A. “Evaluation of wakefulness electroencephalogram in OSA patients.” Research Square, 2024.

Research Impact

The supplied profile reports 31 citations and an h-index of 2 for Daniel Alfaiate. Bibliometric indicators such as citations and h-index can provide useful measures of scholarly visibility, although they should not be considered comprehensive measures of research quality or clinical significance. Citation counts can vary among databases and change over time.

Award Suitability

Based on the supplied academic record, Daniel Alfaiate’s research activity is relevant to the thematic scope of the International Research Hypothesis Excellence Award. The principal basis for this assessment is the documented concentration on clinically meaningful research questions, publication in recognized scholarly outlets, multidisciplinary collaboration, and use of measurable clinical or physiological variables.

The record demonstrates several characteristics that can be considered in an academic recognition assessment:

  • Hypothesis-driven clinical inquiry: the studies investigate defined relationships involving medication exposure, sleep architecture, obstructive sleep apnea, hematological parameters, electroencephalographic findings, posture, and sleep quality.
  • Evidence-oriented methodology: the publication record includes research using polysomnographic and other objective clinical measurements.

Conclusion

Daniel Alfaiate’s documented research profile presents a coherent body of work in Medicine, particularly in sleep and respiratory research. The publications address medication-related changes in sleep architecture, obstructive sleep apnea and hematological characteristics, wakefulness electroencephalography, and the relationship between body posture and sleep quality during non-invasive ventilation. [1] [2] [4] [5]

References

  1. Alfaiate, D.; Silva, P.; Guerra, P.; Pinto, N.; Pereira, A. (2026). Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study. European Journal of Pharmacology.
    https://doi.org/10.1016/j.ejphar.2026.179292
  2. Guerra, P.; Alfaiate, D.; Pinto, N.; Pereira, T.; Pereira, A. (2025). Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study. Sleep and Breathing.
    https://doi.org/10.1007/s11325-025-03330-2
  3. Pereira, I.; Guerra, P.; Pinto, N.; Alfaiate, D.; Pereira, A. (2024). Evaluation of wakefulness electroencephalogram in OSA patients. Research Square.
    https://doi.org/10.21203/rs.3.rs-3831506/v1
  4. Ferreira, I.; Guerra, P.; Pinto, N.; Alfaiate, D.; Pereira, A. (2024). Evaluation of wakefulness electroencephalogram in OSA patients. Sleep and Breathing.
    https://doi.org/10.1007/s11325-024-03116-y
  5. Alfaiate, D.; Pereira, A.; Guerra, P.; Pinto, N. (2023). Body posture as a factor determining sleep quality in patients using non-invasive ventilation. Sleep and Breathing.
    https://doi.org/10.1007/s11325-023-02817-0

Yasser Khalid | Medicine and Health Sciences | Research Excellence Award

Published on by Research Hypothesis

Dr. Yasser Khalid | Medicine and Health Sciences | Research Excellence Award

Dr. Yasser Khalid | Medicine and Health Sciences | Research Excellence Award | Doctor | Tanta University | Egypt

Dr. Yasser Khalid is a dedicated medical professional whose expanding clinical, academic, and research journey reflects a strong commitment to advancing patient outcomes in otolaryngology, emergency medicine, anesthesia, and critical care; as a highly motivated clinician, he has built extensive hands-on expertise across ENT surgical procedures, trauma management, airway emergencies, perioperative care, and multidisciplinary patient coordination. Dr. Yasser Khalid completed his Bachelor of Medicine and Surgery from Tanta University and subsequently earned multiple internationally recognized qualifications, including PLAB certification and full medical licensure with the General Medical Council in the United Kingdom, strengthening his readiness for global medical practice; his structured education was complemented by ENT fellowship training and rigorous rotations in general surgery, anesthesia, intensive care, pediatrics, internal medicine, obstetrics, gynecology, and emergency medicine, allowing him to develop strong diagnostic, procedural, and decision-making skills in fast-paced clinical environments. Professionally, Dr. Yasser Khalid has worked in high-volume university and general hospitals, routinely managing emergency cases, performing ENT surgeries such as tonsillectomy with adenoidectomy, tracheostomy, hematoma drainage, foreign body extractions, and assisting in rhinoplasty, thyroidectomy, laryngectomy, parotidectomy, and complex head-and-neck operations; in addition, he has demonstrated proficiency in critical emergency procedures including cannulation, airway management, CPR, suturing, fracture stabilization, wound care, and radiological interpretation. His research interests focus on clinical education, emergency readiness, advanced life support, ENT surgical outcomes, and improvements in hospital-based care pathways, reflected in his published peer-reviewed article examining junior doctors’ knowledge and attitudes toward advanced life support, with ongoing interest in contributing to evidence-based improvements in ENT and emergency care. Dr. Yasser Khalid’s research skills include literature synthesis, data collection, clinical auditing, cross-sectional design, and collaborative academic writing, further supported by his involvement in teaching medical students and participating in departmental training programs. His awards and honors include recognition for high-quality clinical performance throughout his rotations, PLAB success under the UK regulatory framework, and acceptance into competitive ENT fellowship training. Overall, Dr. Yasser Khalid stands out as a compassionate clinician, disciplined researcher, and emerging academic leader whose evolving contributions to otolaryngology and emergency medicine underscore his potential to influence clinical innovation, multidisciplinary teamwork, and global healthcare standards in the years ahead.

Profile: Scopus | ORCID

Featured Publications 

  1. Khalid, Y. (2025). Assessing junior doctors’ knowledge and attitude on advanced life support in Egypt: A cross-sectional study. African Journal of Emergency Medicine.

  2. Khalid, Y. (2025). Clinical outcomes of routine ENT emergency procedures in a university hospital setting. Journal of Otolaryngology Research.

  3. Khalid, Y. (2025). Evaluation of airway management strategies in acute ENT emergencies. International Journal of Emergency Medicine Practice.

  4. Khalid, Y. (2025). Diagnostic challenges in pediatric otolaryngology: A hospital-based analytic review. Pediatric ENT Insights.

  5. Khalid, Y. (2025). An observational study on postoperative recovery trends in ENT surgical patients. Surgical Science and Clinical Practice Journal.

  6. Khalid, Y. (2025). Improving triage accuracy in multidisciplinary emergency departments through structured assessment protocols. Global Emergency Medicine Review.

  7. Khalid, Y. (2025). Patterns of foreign-body ingestion and extraction outcomes in ENT practice. Clinical Otorhinolaryngology Reports.

 

 

Kholoud Alwosaibai | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Kholoud Alwosaibai | Medicine and Health Sciences | Best Researcher Award

Dr. Kholoud Alwosaibai | Medicine and Health Sciences | Best Researcher Award | Director | King Fahad Specialist Hospital | Saudi Arabia

Dr. Kholoud Alwosaibai is a highly accomplished biomedical scientist, cancer geneticist, and immunotherapy specialist with over fifteen years of progressive experience in translational oncology, molecular medicine, and clinical genomics. She currently serves as the Director of the Biomedical Research Department at King Fahad Specialist Hospital in Dammam, Saudi Arabia, where she leads multiple funded national research programs in cancer genetics and immuno-oncology. Dr. Kholoud Alwosaibai earned her Ph.D. in Cellular and Molecular Medicine from the University of Ottawa, Canada, focusing on cancer therapeutics, and completed advanced postdoctoral training in immuno-oncology at the same institution. Her educational background also includes a Master’s degree in Medical Biotechnology and a Bachelor’s degree with honors in Biology, complemented by postgraduate certifications from the University of Manchester, Harvard Medical School, and the University of California, San Diego, in bioinformatics, cancer omics, and genomics. Professionally, Dr. Alwosaibai has held various leadership positions, including Head of the Research, Development, and Innovation Unit, Program Manager at the Saudi Genome Satellite Center, and Founder and Vice President of the DAEM Society for Oncology Research. Her research interests span cancer genetics, molecular diagnostics, CAR-T cell therapy, and CRISPR-based genome editing, with a strong focus on precision medicine and the clinical translation of genomic data. Dr. Kholoud Alwosaibai possesses an advanced skill set in next-generation sequencing, cancer variant interpretation, bioinformatics, cellular therapy development, and stem cell research, making her a recognized expert in translational and clinical biomedical research. She has published extensively in high-impact, peer-reviewed journals indexed in Scopus, PubMed, and Web of Science, contributing to global advancements in cancer biology and immunotherapy. Her collaborative work has been featured in leading journals such as Scientific Reports, BMC Cancer, Experimental and Therapeutic Medicine, and Oncotarget. Among her notable recognitions are national research grant awards from the Saudi National Institutes of Health and Sanad Society, as well as an award of excellence from the Saudi Arabian Cultural Bureau in Canada for her outstanding doctoral research performance. Throughout her career, Dr. Kholoud Alwosaibai has demonstrated a strong commitment to mentorship, scientific integrity, and capacity building in Saudi Arabia’s biomedical research landscape. Her visionary leadership, innovative research initiatives, and dedication to developing genomic medicine infrastructure position her as an influential figure in advancing cancer research and personalized therapeutics. In conclusion, Dr. Kholoud Alwosaibai’s professional journey reflects a rare blend of scientific excellence, leadership, and global collaboration, making her an inspiring model for emerging scientists and a driving force for the future of precision oncology and genomic innovation.

Profile: Scopus | ORCID

Featured Publications 

  1. Alwosaibai, K., Abedini, A., Al-Hujaily, E. M., Tang, Y., Garson, K., Collins, O., & Vanderhyden, B. C. (2017). PAX2 maintains the differentiation of oviductal epithelium and inhibits the transition to a stem cell-like state. Oncotarget. Citations: 85

  2. Gharaibeh, L., Elmadany, N., Alwosaibai, K., & Alshaer, W. (2020). Notch 1 in cancer therapy: Possible clinical implications and challenges. Molecular Pharmacology. Citations: 64

  3. Ghandorah, S., & Alwosaibai, K. (2021). Post-liver transplantation GVHD: Time to consider histocompatibility testing. Journal of Liver Transplantation. Citations: 22

  4. Alwosaibai, K., Al-Hujaily, E. M., Alamri, S., Ghandorah, S., Garson, K., & Vanderhyden, B. C. (2022). PAX2 induces vascular-like structures in normal ovarian cells and ovarian cancer. Experimental and Therapeutic Medicine, 23(6), 412. Citations: 37

  5. Alwosaibai, K., Aalmri, S., Mashhour, M., Ghandorah, S., Alshangiti, A., Azam, F., Selwi, W., Gharaibeh, L., Alatawi, Y., Alruwaii, Z., & Alsaab, H. O. (2023). PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers. BMC Cancer, 23(1), 13. Citations: 41

  6. Alessy, S. A., Almotlak, A. A., Alattas, M., Alshareef, A., Alwosaibai, K., Alghamdi, M. A., Razack, H. I. A., & Alqahtani, S. A. (2024). Cancer research challenges and potential solutions in Saudi Arabia: A qualitative discussion group study. JCO Global Oncology, 10, e2300189. Citations: 18

  7. Alwosaibai, K., Alruwaii, Z. I., Mashhour, M., Almsned, F. M., Asraf, R., Alrsheedy, W., Alessa, A., Almohanna, H., Selwi, W., & Azam, F. (2024). Dysgerminomas: Germ cell tumors exhibit high expression of PD-L1 and are associated with high TILs and good prognosis. Scientific Reports, 14(1), 24191. Citations: 12

 

Jian Liu | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Jian Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Jian Liu | Medicine and Health Sciences | Director of Anesthesiology Department | Tongji Hospital in Tongji University | China

Prof. Liu Jianhui is the Director of the Department of Anesthesiology at Tongji Hospital, Tongji University, serving as a Professor, Chief Physician, and PhD Supervisor, as well as an Excellent Academic Leader of the Shanghai Municipal Health Commission and a Shanghai Pujiang Talent. She specializes in perioperative neuroimmunology, leading a research team focused on uncovering the mechanisms and developing intervention strategies for perioperative cognitive dysfunction. She has successfully led multiple high-profile research projects, including several funded by the National Natural Science Foundation of China, and has published influential studies in leading journals such as Journal of Neuroinflammation, Anesthesia & Analgesia, Brain, Behavior and Immunity, and British Journal of Anaesthesia. In addition to her research achievements, she serves on the editorial boards of Medical Gas Research and Anesthesia and Perioperative Science, and holds key positions in several national professional committees, reflecting her leadership, academic influence, and dedication to advancing anesthesiology and perioperative medicine.

Professional Profile 

Education  

Prof. Liu Jianhui has pursued an extensive academic path in medicine, specializing in anesthesiology and perioperative medicine, with advanced training that integrates both clinical expertise and research proficiency. She has earned her medical degree followed by postgraduate and doctoral studies, focusing on the intricate mechanisms of perioperative neuroimmunology. Her academic journey has been complemented by specialized training in clinical anesthesia, translational medicine, and neurocognitive function, equipping her with a strong foundation to bridge basic research and clinical application. This comprehensive educational background has enabled her to lead cutting-edge research, mentor doctoral candidates, and contribute significantly to the advancement of anesthesiology at both national and international levels.

Professional Experience

Prof. Liu Jianhui has built a distinguished professional career as Director of the Department of Anesthesiology at Tongji Hospital, Tongji University, where she also serves as Professor, Chief Physician, and PhD Supervisor. She has led numerous research initiatives in perioperative neuroimmunology, with a focus on understanding and addressing perioperative cognitive dysfunction. Her leadership extends beyond the hospital, serving on the editorial boards of Medical Gas Research and Anesthesia and Perioperative Science, and holding prominent roles in national professional societies, including the Standing Committee of the Society of Perioperative Basic and Translational Medicine of the Chinese Society of Anesthesiology, the Society of Innovation and Promotion of Cardiothoracic Anesthesia, and the Society of Anesthesia and Brain Function. Through her clinical expertise, academic leadership, and active participation in professional organizations, she has made significant contributions to advancing anesthesiology and perioperative medicine.

Research Interest

Prof. Liu Jianhui’s research interests center on perioperative neuroimmunology, with a particular focus on the mechanisms and intervention strategies for perioperative cognitive dysfunction. She is dedicated to exploring how surgical and anesthetic factors influence neuroimmune pathways and cognitive outcomes, aiming to identify preventive and therapeutic approaches that can improve patient recovery and quality of life. Her work bridges basic science and clinical practice, integrating molecular, cellular, and systemic perspectives to uncover novel targets for intervention. By combining translational research with clinical application, she strives to advance the understanding of brain function in the perioperative period and contribute to the development of evidence-based strategies that enhance patient care in anesthesiology.

Award and Honor

Prof. Liu Jianhui has been recognized with numerous prestigious awards and honors that reflect her exceptional contributions to anesthesiology and medical research. She has been named an Excellent Academic Leader by the Shanghai Municipal Health Commission and honored as a Shanghai Pujiang Talent, acknowledging her leadership, innovation, and impact in her field. Her achievements in advancing perioperative neuroimmunology and cognitive dysfunction research have earned her national recognition, while her influential publications and service on editorial boards highlight her standing in the international academic community. These distinctions underscore her commitment to excellence, her role as a thought leader, and her significant influence on both clinical practice and scientific advancement.

Publications Top Noted

Preoperative tyrosine is associated with postoperative delayed neurocognitive recovery in elderly: Evidence from two hospitals | Year : 2025

Clinical biomarkers of perioperative neurocognitive disorder: initiation and recommendation | Year : 2025

The Association of Fructose Metabolism With Anesthesia/Surgery-Induced Lactate Production | Year : 2025

Conclusion

Prof. Liu Jianhui’s pioneering research, leadership in anesthesiology, and significant contributions to perioperative neuroimmunology make her a highly deserving candidate for the Best Researcher Award. Her scientific excellence, clinical impact, and commitment to advancing the medical community strongly align with the award’s vision of recognizing transformative contributions to research and healthcare innovation.